PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Proportion of opioid treatment programs offering on-site testing for HIV and STIs declines

2013-12-27
(Press-News.org) Contact information: Kim Newman
Sciencenews@einstein.yu.edu
718-430-3101
The JAMA Network Journals
Proportion of opioid treatment programs offering on-site testing for HIV and STIs declines A survey of opioid treatment programs finds that the proportion offering on-site testing for human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) declined substantially between 2000 and 2011, despite guidelines recommending routine opt-out HIV testing in all health care settings, according to a study appearing in the December 25 issue of JAMA.

"Opioid dependence is a risk factor for HIV, STIs, and hepatitis C virus (HCV) infection. Opioid treatment programs, which provide treatment to more than 300,000 opioid-dependent individuals in the United States, are well-positioned to offer testing for these infectious diseases to a high-risk population. They were among the first venues to offer HIV testing and are more likely to offer HIV, STI, and HCV testing than other drug treatment programs. Private for-profit opioid treatment programs are increasingly widespread and such programs offer on-site HIV testing less often than nonprofit and public programs. However, with the 2006 national recommendations for routine opt-out HIV testing, we hypothesized that the percentage of programs offering on-site testing for HIV, STIs, and HCV would increase," the authors write.

Marcus A. Bachhuber, M.D., and Chinazo O. Cunningham, M.D., M.S., of the Albert Einstein College of Medicine, New York, analyzed data from a survey sent to directors of drug treatment facilities and tabulated the percentage of opioid treatment programs offering on-site HIV, STI, and HCV testing from 2000 to 2011.

The number of U.S. opioid treatment programs increased from 849 in 2000 to 1,175 in 2011. The percentage of programs operating as for-profit businesses increased from 43 percent to 54 percent, nonprofits decreased from 43 percent to 36 percent, and public programs decreased from 14 percent to 10 percent. From 2000 to 2011, the absolute number of programs offering testing for HIV, STIs, and HCV increased but the percentage offering on-site testing for HIV declined by 18 percent and for STIs by 13 percent. There was no change for HCV testing. More than 75 percent of public programs offered on-site testing for each infection, with no change over time.

"Declines were most pronounced in for-profit programs, suggesting that persons enrolled in these programs may be at increased risk for delayed diagnosis and continued transmission of HIV, STIs, and HCV," the authors write.

"Opioid treatment programs are important venues for offering testing to high-risk individuals. As the number of for-profit opioid treatment programs increases, and the opioid, HIV, and HCV epidemics continue to intersect, further work is needed to understand and reverse declines in offering on-site testing."

###

(doi:10.l001/jama.2013.278456; Available pre-embargo to the media at http://media.jamanetwork.com)

Editor's Note: This study was supported by grants from the National Institutes of Health. The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr. Cunningham's husband was recently employed by Pfizer Pharmaceuticals and is currently employed by Quest Diagnostics. No other disclosures were reported.

END



ELSE PRESS RELEASES FROM THIS DATE:

Use of antidepressant does not improve symptoms from stomach disorder

2013-12-27
Use of antidepressant does not improve symptoms from stomach disorder Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall ...

Nonsteroidal anti-inflammatory agent slows rate of progression of neurodegenerative disease

2013-12-27
Nonsteroidal anti-inflammatory agent slows rate of progression of neurodegenerative disease Among patients with familial amyloid polyneuropathy, a lethal, genetic neurodegenerative disease, use of the nonsteroidal anti-inflammatory agent diflunisal compared ...

Prolonged exposure therapy found beneficial in treating adolescent girls with PTSD

2013-12-27
Prolonged exposure therapy found beneficial in treating adolescent girls with PTSD (PHILADELPHIA) – Researchers at Penn Medicine report in the December 25 issue of JAMA that a modified form of prolonged exposure therapy ...

Antidepressants for bipolar disorder

2013-12-27
Antidepressants for bipolar disorder The use of antidepressants in the treatment of bipolar disorder remains controversial. Some studies and treatment guidelines suggest that antidepressant treatment for bipolar disorder may have the potential to increase the manic ...

NASA sees the last of Cyclone Bruce in Southern Indian Ocean

2013-12-27
NASA sees the last of Cyclone Bruce in Southern Indian Ocean Tropical Cyclone Bruce is winding down in the Southern Indian Ocean as wind shear and cooler waters affect the storm. NASA's Aqua satellite flew over Bruce on December 24 and showed that wind shear is having ...

Kinect-based virtual reality training promotes brain reorganization after stroke

2013-12-27
Kinect-based virtual reality training promotes brain reorganization after stroke The Kinect-based virtual reality system for the Xbox 360 enables users to control and interact with the game console without the need to touch a game controller, and provides rehabilitation ...

Activating P300 protein contributes to repair of hippocampal neuronal DNA injuries

2013-12-27
Activating P300 protein contributes to repair of hippocampal neuronal DNA injuries Various medications have been developed to treat neurodegenerative disorders, and drugs without significant side effects are gaining widespread interest such disorders. Brain Research ...

Epigenetics enigma resolved

2013-12-27
Epigenetics enigma resolved First structure of enzyme that removes methylation Scientists have obtained the first detailed molecular structure of a member of the Tet family of enzymes. The finding is important for the field of epigenetics because Tet enzymes chemically ...

Researchers complete a milestone in defining the genetic basis of rheumatoid arthritis

2013-12-27
Researchers complete a milestone in defining the genetic basis of rheumatoid arthritis MANHASSET, NY – An international group of investigators has discovered new genes, pathways and cell types that are involved in inherited susceptibility to rheumatoid ...

International team completes systematic, genomic study of cervical cancer

2013-12-27
International team completes systematic, genomic study of cervical cancer Findings point to potential therapeutics, shed light on HPV role Researchers from the Boston area, Mexico, and Norway have completed a comprehensive genomic analysis of cervical ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Proportion of opioid treatment programs offering on-site testing for HIV and STIs declines